General
South African variant of COVID-19 can ‘break through’ Pfizer vaccine, Israeli study says
The coronavirus variant discovered in South Africa can “break through” the Pfizer COVID-19 vaccine to some extent, a real-world data study in Israel has found, though its prevalence in the country is low and the research has not been peer reviewed.
Key points:
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease.
It matched age and gender, among other characteristics.
The South African variant, B.1.351, was found to make up about 1 per cent of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel’s largest…
-
Noosa News17 hours agoToombul Shopping Centre site thrown lifeline after Mirvac announces sale with ‘priority’ to build new retail centre
-
General17 hours agoAllegations against ex-Attorney-General Mark Dreyfus removed from Linda Reynolds action against Commonwealth
-
Noosa News19 hours agoMirvac to sell site to Irvine Group
-
General16 hours agoWoolworths executive was hospitalised by 100-hour-a-week workload, lawsuit claims